Fudan University: all 1,308 studies
Page 2 of 14. Open to participants first (637), then studies with results posted, then the rest; newest registration first within each.
- The Effects of a Nurse-led TGA-based Pre-rehabilitation Planning on Perioperative Outcomes in Patients With Liver Cancer: Study and ProtocolEnrolling by invitationNCT07537205Not applicable
- Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular CarcinomaRecruitingNCT07536789Phase 2
- Tpex Subsets in Negative Tumor Draining Lymph Nodes for Predicting the Efficacy of PD 1 Inhibitors in Advanced or Recurrent Esophageal Squamous Cell CarcinomaNot yet recruitingNCT07533357
- Artificial Intelligence Model-Guided Neoadjuvant Anti-HER2 Targeted TherapyRecruitingNCT07528716Phase 3
- Neoadjuvant Moderately Hypofractionated Radiotherapy Combined With Chemotherapy and Immunotherapy for High-risk pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Multi-center Randomized Control Phase II TrialNot yet recruitingNCT07527520Phase 2
- Dynamic Circulating Tumor DNA Monitoring to Guide Systemic Therapy in Gastric CancerRecruitingNCT07517107Phase 2
- Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT07515625Phase 2
- Iparomlimab Plus Tovorilimab Combined With Bevacizumab and Chemotherapy as First-Line Treatment for Advanced MesotheliomaNot yet recruitingNCT07514793Phase 2
- QLC5513 Alone or in Combination With QL1706 in Previously Treated Advanced or Metastatic TNBC.Not yet recruitingNCT07509515Phase 2
- Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT07507916Phase 2
- Air Purifier Use and Respiratory Health in COPD PatientsRecruitingNCT07505602Not applicable
- Umbrella Trial of Neoadjuvant Therapy for Locally Advanced Colorectal CancerNot yet recruitingNCT07503639Phase 2
- A Study of Becotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive Advanced Penile CancerRecruitingNCT07497919Phase 2
- A Clinical Study of Sintilimab Combined With Chemothrapy Versus Chemotherapy as Adjuvant Therapy for Gastric/Gastroesophageal Junction AdenocarcinomaRecruitingNCT07492615Phase 2
- Mesh Infection After Hernioplasty: Complete vs Partial Removal - Retrospective Study on Outcomes and Pathogen AnalysisNot yet recruitingNCT07491250
- Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate CancerNot yet recruitingNCT07490210Phase 2
- Becotatug Vedotin Combined With Cetuximab in the Later-line Treatment of Metastatic RAS Wild-type Colorectal CancerNot yet recruitingNCT07490119Phase 2
- Eribulin Mesylate-based Therapy in Patients With Advanced HER2-negative Breast Cancer Previously Treated With ADCNot yet recruitingNCT07480694
- Study on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast CancerRecruitingNCT07471776Phase 2
- Level I-II Axillary Irradiation in Breast Cancer With Sentinel-Node Macro-metastasesRecruitingNCT07469267Not applicable
- Study of MRI Guided Personal Chemoradiotherapy and Immunotherapy for Limited Advanced Esophageal Squamous Caicinoma.Not yet recruitingNCT07469241Phase 2
- Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With HER2-negative Breast Cancer With Liver MetastasesNot yet recruitingNCT07466927Phase 2
- Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic MalignanciesRecruitingNCT07459309Not applicable
- SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPCRecruitingNCT07451795Phase 2
- RWS of Tunlametinib in NRAS-Mutant Advanced MelanomaRecruitingNCT07445022Phase 4
- Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases CancerEnrolling by invitationNCT07441369Phase 2
- An Observational Study on Gastric Cancer in High-risk IndividualsNot yet recruitingNCT07438418
- CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer（Cinnamon）RecruitingNCT07432178Phase 3
- ctDNA-Guided Chemotherapy Omission With Ribociclib Plus Endocrine Therapy in HR-Positive/HER2-Negative Breast CancerNot yet recruitingNCT07423611Phase 2
- Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast CancerNot yet recruitingNCT07419880Phase 2
- A Platform Study Based on Specific Tracer for Evaluating the Therapeutic Efficacy of Systemic Treatment for Breast Cancer Using PET/MRINot yet recruitingNCT07419867Phase 2
- A Real-world Study of Pralsetinib Combined With Leucogen in the Treatment of RET Fusion-positive NSCLCNot yet recruitingNCT07418879Not applicable
- FANLUNG-2：The Value of High-Low Mixed-Dose Radiotherapy Combined With Chemo-Immunotherapy Induction in Locally Advanced Non-Small Cell Lung CancerNot yet recruitingNCT07418866Phase 2
- Lenvatinib and Pembrolizumab With or Without BCAA in Unresectable HCCNot yet recruitingNCT07412054Phase 2
- AI-Enhanced Imaging in Population Breast Cancer ScreeningRecruitingNCT07411443Not applicable
- Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast CancerNot yet recruitingNCT07410559Phase 2
- Adjuvant Intensification for LARNot yet recruitingNCT07407517Phase 3
- Neoadjuvant Immunotherapy ± Radiotherapy in MSI-H/dMMR Locally Advanced Colorectal CancerNot yet recruitingNCT07403877Phase 2
- Becotatug Vedotin ± Anti-PD-1 in Pretreated Advanced ESCCRecruitingNCT07403136Phase 2
- The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut MicrobiotaRecruitingNCT07400354
- Comparison of Serplulimab Versus Nivolumab in Neoadjuvant Therapy for Resectable Stage II-IIIA Squamous NSCLCRecruitingNCT07398937Phase 2
- The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive ImpairmentRecruitingNCT07395960Phase 1/2
- Pucotenlimab Combined With Becotatug Vedotin in Advanced Cutaneous Squamous Cell CarcinomaNot yet recruitingNCT07394244Phase 2
- ctDNA-guided Treatment Decision-makingRecruitingNCT07394218Phase 2
- Integrated Clinical-molecular Risk Stratification to Early Recurrence in Colorectal Liver MetastasesNot yet recruitingNCT07391007
- Albumin-bound Paclitaxel-based Second-line Treatment Regimens for Locally Advanced or Metastatic G/GEJ AdenocarcinomaRecruitingNCT07389876
- Famitinib Combined With SHR-A1811, Versus SHR-A1811 for CDK4/6 Inhibitors-resistent Advanced HR+/HER2- Breast Cancer With SNF4 SubtypeNot yet recruitingNCT07382687Phase 3
- Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative DisordersRecruitingNCT07381738Phase 2
- Comparative Study on the Short- and Long-term Efficacy of Q-ISR, Traditional Sub-ISR, and t-ISRRecruitingNCT07371273Phase 2
- Sequencing SG vs. T-DXd in HER2-Low/TROP2-High Metastatic Breast CancerNot yet recruitingNCT07368543Phase 2
- RC48 Combined With Chemotherapy in HER2-Positive Advanced Breast Cancer Patients With Prior TOP1i-ADC FailureNot yet recruitingNCT07366840Phase 2/3
- Corticosteroids for Doxorubicin Liposome-Induced Hand-Foot-Skin ReactionsRecruitingNCT07362914Phase 3
- Fruquintinib Versus Bevacizumab Plus Chemotherapy in Second-Line RAS-Mutant Metastatic Colorectal Cancer (FRU-RAS)Not yet recruitingNCT07362836Phase 3
- G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell TransplantationRecruitingNCT07362810Phase 2
- Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer PatientsNot yet recruitingNCT07358520Phase 4
- A Clinical Study on the Efficacy and Safety of All-trans Retinoic Acid Combined With VAC Regimen in the Treatment of Intermediate-to-high-risk RhabdomyosarcomaNot yet recruitingNCT07355855Phase 2
- Huaier Granule and ProteinuriaNot yet recruitingNCT07355361Phase 2
- Fluzoparib as Adjuvant Treatment in Patients With Germline Homologous Recombination Repair (HRR) Mutated Primary Breast Cancer (Flamenco)Not yet recruitingNCT07353437Phase 2
- Iparomlimab and Tuvoraleimab Injection in Combination With Bevacizumab, Albumin-bound Paclitaxel, and Carboplatin as First- or Second-line Treatment for Patients With Advanced Acral and Mucosal MelanomaNot yet recruitingNCT07347444Phase 2
- A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular CarcinomaRecruitingNCT07328009Phase 2
- Evaluating the Predictive Capability of Transcriptomic Profiling for Identifying the Primary Site of Metastatic TumorsNot yet recruitingNCT07319949
- Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular ClassificationRecruitingNCT07319429Phase 2/3
- Real-World Study of Toripalimab in Extensive-Stage Small Cell Lung CancerNot yet recruitingNCT07308379
- AI for Renal Tumors Using Non-Contrast CTNot yet recruitingNCT07304492
- Individualized Neck Cervical Irradiation Prophylaxis Trial of NPCRecruitingNCT07303023Phase 3
- Population Pharmacokinetics of Remifentanil in Low-Weight Critically Ill PatientsRecruitingNCT07301970
- Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell LymphomaRecruitingNCT07300514Phase 3
- Adjuvant Chemotherapy for BTC Based on 3D-PTANot yet recruitingNCT07296666Phase 2
- A Phase II Study to Evaluate the Efficacy and Safety of Anti-HER2 Triple-targeted Drugs Combined With CDK4/6 Inhibitors in Neoadjuvant Therapy for ER-positive HER2-positive Breast Cancer Patients.Not yet recruitingNCT07290166Phase 2
- Psychological State, Immunotherapy Response, and Multi-Omics Signatures in TNBCRecruitingNCT07290153
- Chinese Herbal Therapy (Qiqi Shengmai Formula) for Moyamoya Vasculopathy: The CHIMES TrialNot yet recruitingNCT07286110Phase 1
- Using ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET)RecruitingNCT07283575
- The Fever Clinic Acute Respiratory CohortRecruitingNCT07278700
- Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric RetentionNot yet recruitingNCT07276763
- Omega-3 Fatty Acids With PD-1 Inhibitors in Advanced Esophageal CancerRecruitingNCT07272382Not applicable
- Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related DiabetesNot yet recruitingNCT07272109Phase 3
- Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort StudyRecruitingNCT07270861
- CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate CancerNot yet recruitingNCT07268794Phase 2
- TITAN-HCC: Neoadjuvant and Adjuvant QL1706 With TACE in Resectable Hepatocellular Carcinoma Beyond Milan CriteriaRecruitingNCT07268131Not applicable
- Effect of OFA, OSA Versus Opioid-based Anesthesia on NETs and Cancer Cell Malignancy After Colorectal Cancer SurgeryRecruitingNCT07264556Not applicable
- Evaluating the Clinical Value of Transparent Cap-Assisted Second Examination of the Sigmoid Colon for Improving Colorectal Adenoma Detection RatesNot yet recruitingNCT07261319Not applicable
- AI-assisted Integrated Care to Promote Colonoscopy UptakeNot yet recruitingNCT07261059Not applicable
- A Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver SpreadNot yet recruitingNCT07256223Phase 2
- Predictive Factors for the Efficacy of CD19 CAR-T Therapy in Relapsed/Refractory Large B-Cell Lymphoma: A Clinical StudyRecruitingNCT07236203
- MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTCRecruitingNCT07235566Phase 2
- CDK4/6 Inhibitor Intensification and Chemotherapy De-Escalation for Early-stage Luminal-HER2 Breast CancerNot yet recruitingNCT07213206Phase 3
- DV+BCG in HER2-Expressing, BCG-Naïve High-Risk NMIBCRecruitingNCT07207824Phase 3
- A Multicenter, Single-arm, Prospective Phase II Clinical Study of Epalrotokewali Combined With Eribulin, Anlotinib, and Radiotherapy for the Treatment of Patients With Advanced Soft Tissue Sarcoma.Not yet recruitingNCT07205185Phase 2
- Evaluation of a Vaccine Chatbot on HPV Vaccine Confidence and HesitancyNot yet recruitingNCT07200570Not applicable
- Study on the Mechanism of Acquired Resistance of EntrectinibRecruitingNCT07199959
- Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric CancerRecruitingNCT07194005Phase 2
- Anlotinib and Benmelstobart in DTCNot yet recruitingNCT07193186Phase 2
- Sacituzumab Tirumotecan in Combination With Furmonertinib as Second-line Treatment for EGFR-mutant Advanced or Metastatic NSCLC After Failure of First-line Third-generation EGFR-TKI TherapyNot yet recruitingNCT07193160Phase 2
- Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)RecruitingNCT07183865Phase 2
- Multicentric Database for Solid Pseudopapillary Neoplasm of the PancreasRecruitingNCT07183280
- SKB264 Plus Inetetamab in HER2-Positive Metastatic Breast Cancer Patients Progressing After T-DXd TreatmentRecruitingNCT07182721Phase 2
- Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II StudyNot yet recruitingNCT07179939Phase 2
- Yueju Pill Combined With Standard Therapy In Advanced Biliary Tract CancerNot yet recruitingNCT07169916Not applicable
- Incidence of 106TBL Lymph Node MetastasisRecruitingNCT07165210
- Incidence of 107 Lymph Node MetastasisRecruitingNCT07165184